TaiRx, Inc. (TPEX:6580)
10.60
-0.75 (-6.61%)
Nov 20, 2026, 1:33 PM CST
TaiRx Revenue
TaiRx had revenue of 9.07M TWD in the half year ending June 30, 2026, with 3,323.77% growth. This brings the company's total for the last twelve months to 29.44M, up 90.44% year-over-year. In the year 2025, TaiRx had annual revenue of 27.88M with 239.03% growth. That makes TaiRx the 43,813th largest company in the world by revenue and 2,159th in Taiwan.
Revenue (ttm)
29.44M
Revenue Growth
+90.44%
P/S Ratio
40.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.88M | 19.65M | 239.03% |
| Dec 31, 2024 | 8.22M | 3.14M | 61.79% |
| Dec 31, 2023 | 5.08M | -1.84M | -26.59% |
| Dec 31, 2022 | 6.92M | 1.78M | 34.66% |
| Dec 31, 2021 | 5.14M | 1.78M | 53.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.03B |
| GenMont Biotech Incorporation | 396.64M |
| Abnova (Taiwan) | 337.63M |
| NeoCore Technology | 271.62M |
| Sunny Pharmtech | 233.36M |
| Anti-Microbial Savior BioteQ | 1.26M |